Compile Data Set for Download or QSAR
maximum 50k data
Found 136 of ki data for polymerid = 1001
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214466(CHEMBL398149 | N-(3-(8-cyano-4-(cyclopropylamino)p...)
Affinity DataKi:  0.260nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214473(CHEMBL230354 | N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZO...)
Affinity DataKi:  0.350nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
Affinity DataKi:  0.380nMAssay Description:Inhibition of CK2alpha (unknown origin) using RRRADDSDDDDD as substrate in presence of [gamma33P]-ATP by autoradiographyMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214454(CHEMBL230462 | N-(3-(8-cyano-4-(cyclobutylamino)py...)
Affinity DataKi:  1.90nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214444(2-(p-toluidino)-4-(phenylamino)pyrazolo[1,5-a][1,3...)
Affinity DataKi:  5nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214465(2-(4-chlorobenzylamino)-4-(phenylamino)pyrazolo[1,...)
Affinity DataKi:  5nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50508987(CHEMBL4465651)
Affinity DataKi:  7nMAssay Description:Inhibition of CK2alpha (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214477(4-(phenylamino)-2-(4-(pyridin-2-yl)piperazin-1-yl)...)
Affinity DataKi:  7nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214474(CHEMBL230353 | N-(3-(8-cyano-4-(phenethylamino)pyr...)
Affinity DataKi:  8nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214460(2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[...)
Affinity DataKi:  8nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214448(2-(3,4-dimethoxyphenylamino)-4-(phenylamino)pyrazo...)
Affinity DataKi:  9nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214464(CHEMBL230568 | N-(3-(8-methyl-4-(phenylamino)pyraz...)
Affinity DataKi:  11nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214450(2-(3,4-dihydroisoquinolin-2(1H)-yl)-4-(phenylamino...)
Affinity DataKi:  11nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214457(2-(2,3-dihydro-1H-inden-2-ylamino)-4-(phenylamino)...)
Affinity DataKi:  12nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214453(2-(isopentylamino)-4-(phenylamino)pyrazolo[1,5-a][...)
Affinity DataKi:  13nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50359842(CHEMBL1928905)
Affinity DataKi:  13nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BL21 (DE3) assessed as [33P]gamma-ATP incorporation into RRRADDSDDDDD s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214468(4-(phenylamino)-2-(pyrrolidin-1-yl)pyrazolo[1,5-a]...)
Affinity DataKi:  14nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214446(2,4-bis(phenylamino)pyrazolo[1,5-a][1,3,5]triazine...)
Affinity DataKi:  15nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214443(CHEMBL230673 | N-(3-(8-bromo-4-(cyclopropylamino)p...)
Affinity DataKi:  17nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM4078(6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0...)
Affinity DataKi:  20nMAssay Description:Inhibition of CK2alpha (unknown origin)More data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214471(2-(4-(diethylamino)phenylamino)-4-(phenylamino)pyr...)
Affinity DataKi:  23nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214452(2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[...)
Affinity DataKi:  24nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50420549(CHEMBL2087008)
Affinity DataKi:  32nMAssay Description:Inhibition of CK2alpha (unknown origin) using RRRADDSDDDDD as substrate in presence of [gamma33P]-ATP by autoradiographyMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214451(CHEMBL230463 | N-(3-(4-(cyclopropylamino)-8-methyl...)
Affinity DataKi:  35nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50156670(2-(dimethylamino)-4,5,6,7-tetrabromo-1H-benzimidaz...)
Affinity DataKi:  40nMAssay Description:Binding affinity to CK2alpha (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50156669(4,5,6,7-TETRABROMO-BENZIMIDAZOLE | 4,5,6,7-tetrabr...)
Affinity DataKi:  40nMAssay Description:Inhibition of CK2alpha in human PLC1 cells using (Arg)3(Glu)3Thr(Glu)3 as substrate after 24 hrs in presence of [32P]gammaGTPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM34038(4,5,6,7-tetraiodobenzimidazole (TIBI), 1a)
Affinity DataKi:  43nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BL21 (DE3) assessed as [33P]gamma-ATP incorporation into RRRADDSDDDDD s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50156669(4,5,6,7-TETRABROMO-BENZIMIDAZOLE | 4,5,6,7-tetrabr...)
Affinity DataKi:  45nMAssay Description:Inhibition of human wild type CK2alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214470(2-(1H-imidazol-2-ylamino)-4-(phenylamino)pyrazolo[...)
Affinity DataKi:  45nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214478(2-(benzyl(methyl)amino)-4-(phenylamino)pyrazolo[1,...)
Affinity DataKi:  55nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50508989(CHEMBL273101)
Affinity DataKi:  60nMAssay Description:Inhibition of CK2alpha (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50041419(1,2,5,8-tetrahydroxy-9,10-anthracenedione | 1,2,5,...)
Affinity DataKi:  60nMAssay Description:Inhibition of CK2alpha (unknown origin)More data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50156368(CHEMBL608394)
Affinity DataKi:  70nMAssay Description:Inhibition of human wild type CK2alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50347922(CHEMBL270724)
Affinity DataKi:  77nMAssay Description:Inhibition of CK2alpha (unknown origin) using RRRADDSDDDDD as substrate in presence of [gamma33P]-ATP by autoradiographyMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50359841(CHEMBL1928904)
Affinity DataKi:  77nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BE21 (DE3) assessed as [33P]gamma-ATP incorporation into P2B substrate ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM34053(iodinated benzimidazole, 16)
Affinity DataKi:  80nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BL21 (DE3) assessed as [33P]gamma-ATP incorporation into RRRADDSDDDDD s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50359846(CHEMBL1233807)
Affinity DataKi:  83nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BL21 (DE3) assessed as [33P]gamma-ATP incorporation into RRRADDSDDDDD s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50359844(CHEMBL1928907)
Affinity DataKi:  88nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BE21 (DE3) assessed as [33P]gamma-ATP incorporation into P2B substrate ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50359846(CHEMBL1233807)
Affinity DataKi:  88nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BE21 (DE3) assessed as [33P]gamma-ATP incorporation into P2B substrate ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214445(3-(2-(3-acetamidophenylamino)-8-cyanopyrazolo[1,5-...)
Affinity DataKi:  95nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50156670(2-(dimethylamino)-4,5,6,7-tetrabromo-1H-benzimidaz...)
Affinity DataKi:  97nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BE21 (DE3) assessed as [33P]gamma-ATP incorporation into P2B substrate ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50156673(((4,5,6,7-tetrabromo-1H-benzimidazol-2-yl)sulfanyl...)
Affinity DataKi:  106nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BE21 (DE3) assessed as [33P]gamma-ATP incorporation into P2B substrate ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM34053(iodinated benzimidazole, 16)
Affinity DataKi:  110nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BE21 (DE3) assessed as [33P]gamma-ATP incorporation into P2B substrate ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50359843(CHEMBL1928906)
Affinity DataKi:  112nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BE21 (DE3) assessed as [33P]gamma-ATP incorporation into P2B substrate ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50359840(CHEMBL1928903)
Affinity DataKi:  116nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BE21 (DE3) assessed as [33P]gamma-ATP incorporation into P2B substrate ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214479(2-(1H-imidazol-1-yl)-4-(phenylamino)pyrazolo[1,5-a...)
Affinity DataKi:  126nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214475(4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)...)
Affinity DataKi:  137nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50214456(2-(p-toluidino)-4-(phenethylamino)pyrazolo[1,5-a][...)
Affinity DataKi:  137nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50359843(CHEMBL1928906)
Affinity DataKi:  137nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BL21 (DE3) assessed as [33P]gamma-ATP incorporation into RRRADDSDDDDD s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Polaris Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50156670(2-(dimethylamino)-4,5,6,7-tetrabromo-1H-benzimidaz...)
Affinity DataKi:  139nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BL21 (DE3) assessed as [33P]gamma-ATP incorporation into RRRADDSDDDDD s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 136 total ) | Next | Last >>
Jump to: